Swissmedic Vigilance-News Edition 28 – Mai 2022
In dieser Ausgabe: COVID-19-Impfungen: Aktualisierungen der Fachinformationen seit Zulassung; Myokarditis, Thromboembolische Ereignisse, Multiple Sklerose; Persistierende Kopfschmerzen; Methoden der Signaldetektion / «Observed versus Expected» Analysen
In dieser Ausgabe: COVID-19-Impfungen:
Aktualisierungen der Fachinformationen seit Zulassung;
Myokarditis, Thromboembolische Ereignisse, Multiple Sklerose;
Persistierende Kopfschmerzen;
Methoden der Signaldetektion / «Observed versus Expected» Analysen
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
(5) Risk Factors for Venous Thromboembolism [Internet].<br />
[cité 23 mars <strong>2022</strong>]. Disponible sur:<br />
https://www.ahajournals.org/doi/epub/10.1161/01.CIR.0000078469.07<br />
362.E6<br />
(6) Actualité - Point de situation sur la surveillance<br />
des vaccins contre la Covid-19 - Période du<br />
25/02/<strong>2022</strong> au 10/03/<strong>2022</strong> - ANSM [Internet]. [cité<br />
21 mars <strong>2022</strong>]. Disponible sur:<br />
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-25-02-<strong>2022</strong>-au-10-03-<strong>2022</strong><br />
(7) Carli G, Ilaria Nichele, Marco Ruggeri, Salvatore<br />
Barra, Alberto Tosetto. Deep vein thrombosis<br />
(DVT) occurring shortly after the second dose of<br />
mRNA SARS-CoV-2 vaccine | SpringerLink [Internet].<br />
[cité 29 mars <strong>2022</strong>]. Disponible sur:<br />
https://link.springer.com/article/10.1007/s11739-<br />
021-02685-0<br />
(8) Zakaria Z, Sapiai NA, Ghani ARI. Cerebral venous<br />
sinus thrombosis 2 weeks after the first dose of<br />
mRNA SARS-CoV-2 vaccine. Acta Neurochir. 1<br />
août 2021;163(8):2359-62.<br />
(9) Al-Maqbali JS, Rasbi SA, Kashoub MS, Hinaai<br />
AMA, Farhan H, Rawahi BA, et al. A 59-Year-Old<br />
Woman with Extensive Deep Vein Thrombosis<br />
and Pulmonary Thromboembolism 7 Days Following<br />
a First Dose of the Pfizer-BioNTech BNT162b2<br />
mRNA COVID-19 Vaccine. Am J Case Rep. 12 juin<br />
2021;22:e932946-1-e932946-4.<br />
(10) Dias L, Soares-dos-Reis R, Meira J, Ferrão D, Soares<br />
PR, Pastor A, et al. Cerebral Venous Thrombosis<br />
after BNT162b2 mRNA SARS-CoV-2 vaccine. Journal<br />
of Stroke and Cerebrovascular Diseases [Internet].<br />
1 août 2021 [cité 29 mars <strong>2022</strong>];30(8). Disponible<br />
sur: https://www.strokejournal.org/article/S1052-3057(21)00309-8/abstract<br />
(11) Bhan C, Bheesham N, Shakuntulla F, Sharma M,<br />
Sun C, Weinstein M. An unusual presentation of<br />
acute deep vein thrombosis after the Moderna<br />
COVID-19 vaccine—a case report. Ann Transl<br />
Med. oct 2021;9(20):1605.<br />
(12) Klein NP, Lewis N, Goddard K, Fireman B, Zerbo<br />
O, Hanson KE, et al. Surveillance for Adverse<br />
Events After COVID-19 mRNA Vaccination. JAMA.<br />
12 oct 2021;326(14):1-10.<br />
(13) Mj J, J B, M B, A W, P F, M Z, et al. Myocardial<br />
Infarction, Stroke, and Pulmonary Embolism After<br />
BNT162b2 mRNA COVID-19 Vaccine in People<br />
Aged 75 Years or Older. JAMA [Internet]. 1 avr<br />
<strong>2022</strong> [cité <strong>28</strong> mars <strong>2022</strong>];327(1). Disponible sur:<br />
https://pubmed.ncbi.nlm.nih.gov/34807248/<br />
(14) Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman<br />
J, Ohana R, et al. Safety of the BNT162b2<br />
mRNA Covid-19 Vaccine in a Nationwide Setting.<br />
N Engl J Med. 25 août 2021;385(12):1078-90.<br />
<strong>Swissmedic</strong> <strong>Vigilance</strong>-<strong>News</strong> | <strong>Edition</strong> <strong>28</strong> <strong>–</strong> <strong>Mai</strong> <strong>2022</strong> 22 | 45
Change language